- Home
- YMAT vs ABOS Comparison
YMAT vs ABOS Comparison
Compare YMAT & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAT
- ABOS
- Stock Information
- Founded
- YMAT 1970
- ABOS 1996
- Country
- YMAT Taiwan
- ABOS United States
- Employees
- YMAT N/A
- ABOS N/A
- Industry
- YMAT Recreational Games/Products/Toys
- ABOS Biotechnology: Pharmaceutical Preparations
- Sector
- YMAT Consumer Discretionary
- ABOS Health Care
- Exchange
- YMAT Nasdaq
- ABOS Nasdaq
- Market Cap
- YMAT 76.4M
- ABOS 90.3M
- IPO Year
- YMAT 2025
- ABOS 2021
- Fundamental
- Price
- YMAT N/A
- ABOS $1.35
- Analyst Decision
- YMAT
- ABOS Strong Buy
- Analyst Count
- YMAT 0
- ABOS 3
- Target Price
- YMAT N/A
- ABOS $6.33
- AVG Volume (30 Days)
- YMAT 2.0M
- ABOS 588.6K
- Earning Date
- YMAT 01-01-0001
- ABOS 08-12-2025
- Dividend Yield
- YMAT N/A
- ABOS N/A
- EPS Growth
- YMAT N/A
- ABOS N/A
- EPS
- YMAT 0.07
- ABOS N/A
- Revenue
- YMAT $17,563,985.00
- ABOS N/A
- Revenue This Year
- YMAT N/A
- ABOS N/A
- Revenue Next Year
- YMAT N/A
- ABOS N/A
- P/E Ratio
- YMAT $64.10
- ABOS N/A
- Revenue Growth
- YMAT N/A
- ABOS N/A
- 52 Week Low
- YMAT $3.80
- ABOS $0.86
- 52 Week High
- YMAT $4.88
- ABOS $3.36
- Technical
- Relative Strength Index (RSI)
- YMAT N/A
- ABOS 48.03
- Support Level
- YMAT N/A
- ABOS $1.35
- Resistance Level
- YMAT N/A
- ABOS $1.60
- Average True Range (ATR)
- YMAT 0.00
- ABOS 0.13
- MACD
- YMAT 0.00
- ABOS -0.03
- Stochastic Oscillator
- YMAT 0.00
- ABOS 17.31
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.